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Summary. Insulin-dependent diabetes mellitus (IDDM) 
is caused by autoimmune destruction of pancreatic beta 
cells with the primary mechanism being cell mediated. 
The BB rat develops insulitis and IDDM with many 
features analogous to the disease in man. In previous 
studies we reported that weekly administration of 2'- 
deoxycoformycin (dCF) for four months reduces 
significantly the incidence of IDDM in the BB rat by 
70%, and that the animals remain free of diabetes for a 
minimum of two months after drug withdrawal. Since 
the diabetes-prone BB rat is lymphopenic, with a 
reduction of both CD4 and CD8 cells, the continuous 
failure of dCF treated animals to develop diabetes may 
have been due to generalized immunosuppression. To 
test this possibility, the ability of dCF treated diabetes- 
free BB rats to mount an immune response after 
challenge with Ovalbumin was examined five months 
after drug withdrawal. The results showed that the post- 
immunization levels of total IgG and specific IgG in 
these animals did not differ from those observed in non- 
dCF treated controls nor those of control diabetes- 
resistant non-lymphopenic BB rats. Moreover, FACS 
analysis indicated no change in the percentages or total 
numbers of CD4t or CD8+ cells between the two groups 
of animals. Histological assessment of the pancreata of 
the post-dCF treated animals showed varying degrees of 
mononuclear cell infiltrates in the islets. These data 
demonstrate that treatment by dCF is not permanent, and 
may require intermittent or continuous administration to 
prevent development of diabetes. Further studies are 
needed to determine the mechanism of action of dCF in 
this model of IDDM. 
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Introduction 
Development of insulin-dependent diabetes mellitus 
(IDDM) results from the autoimmune destruction of 
pancreatic beta cells,  with macrophages and T 
lymphocytes playing an essential role (Lee et al., 1988; 
Boitard et al., 1991). Clinical studies with immuno- 
suppressive agents, such as cyclosporine, prednisone, 
azathioprine and anti-lyrnphocyte globulin, which have 
been used to prevent the progression of diabetes have 
produced significant adverse effects, most notable 
nephrotoxicity (Wilson and Eisenbarth, 1990; Martin et 
al., 1991). Moreover, clinical symptoms of IDDM 
redevelops in all patients within six months after 
discontinuation of drug therapy. Thus, at present there 
are no safe and efficacious drugs available to treat 
IDDM and prevent insulin dependency. 
The purine nucleoside analogs fludarabine, 2- 
chlorodeoxyadenosine, and 2'-deoxycoformycin exhibit 
impressive activity in lymphoproliferative malignancies 
of adults and children (Slomiany et al., 1997). Their 
mechanism of action is not clear. Studies have suggested 
that their use is associated with significant myelo- 
suppression, immunosuppression, and in some 
circumstances, increased infection with viral and 
opportunist ic  pathogens (Johnston et  al., 1988; 
Catovsky, 1996; Slomiany et al., 1997). We recently 
examined the immunosuppressive effects of 2'- 
deoxycoformycin (dCF) by assessing its ability to 
prevent induction of diabetes in the BB Wistar rat, a 
strain that spontaneously develops insulitis and IDDM, 
exhibiting many features similar to the human disease 
(Marliss et al., 1982; Castano and Eisenbarth, 1990). In 
that study, a linear dose effect was observed with 
protection against IDDM, and 80% of the animals 
remained free of diabetes at the highest dose tested, i.e, 
10 mg/kg/wk two months following cessation of dCF 
treatment (Thliveris et al., 1997). 
Strikingly, subsequent monitoring demonstrated that 
the protective effect persisted for at least five months 
following discontinuation of this drug. We speculated 
that the protective effect of dCF against IDDM is  






